✦ LIBER ✦

Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin

✍ Scribed by Giuseppe Derosa; Amedeo Mugellini; Leonardina Ciccarelli; Giuseppe Crescenzi; Roberto Fogari

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P0583 SAXAGLIPTIN EITHER AS ADD-ON THERA

✍ Irina Gurieva; Andreas Pfützner; Mikhail Antsiferov; Elsie Allen; Shoba Ravichan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Targeting hyperglycaemia with either met

✍ S. S. Lund; L. Tarnow; C. D. A. Stehouwer; C. G. Schalkwijk; M. Frandsen; U. M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Cardiovascular risk factors and LDL subf

✍ C.E. Tan; L.S. Chew; L.F. Chio; E.S. Tai; H.S. Lim; S.C. Lim; L. Jayakumar; H.K. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 82 KB

An audit of glycaemic control and cardio

✍ P. Downey; L. O’Shea; D. Dillon; M. Corbett; S. Sreenan 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 726 KB

Comparison of glycaemic control over 1 y

✍ G. Perriello; S. Pampanelli; C. Di Pietro; P. Brunetti; on behalf of the Italian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Initial treatment with rosiglitazone/met

✍ J. Rosenstock; J. Rood; A. Cobitz; N. Biswas; H. Chou; A. Garber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB